Hofseth BioCare ASA (0Q6H.L)
| Previous close | 0.0000 |
| Open | 0.0000 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 0.54 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3780 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Globe Newswire
Hofseth Biocare ASA: HBC ANNUAL REPORT 2022
The Board of Directors of Hofseth BioCare ASA (“HBC”) has approved the financial statements for 2022 and the Company has today published the Annual Report and Sustainability Report for 2022. Please find the Annual Report and ESG Report attached. For further information, please contact:Jon Olav Ødegård, CEO of Hofseth BioCare ASAPhone: +47 93632966E-mail: joo@hofsethbiocare.no About Hofseth BioCare ASA HBC is a Norwegian consumer and pet health ingredient supplier and an incubator for new pharmac
- Globe Newswire
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
Bomi Framroze Holding AS, a close associate of primary insider and Chief Scientific Officer Dr. Bomi Framroze in Hofseth Biocare ASA ("HBC"), has on 27 February 2023 purchased 200,000 shares in HBC at a price of NOK 2.69 per share. Please see the attached notification form for further information. Jon Olav Ødegård, CEO of Hofseth BioCare ASAPhone: +47 936 32 966E-mail: joo@hofsethbiocare.no This information is subject to the disclosure requirements in the Market Abuse Regulation EU 596/2014 arti
- Globe Newswire
Hofseth Biocare ASA: FOURTH QUARTER 2022 & FULL YEAR FINANCIAL REPORT
In Q4, the ingredients business continued to show favorable momentum with growth of 87 %, compared to same quarter last year on an underlying basis, generating sales revenues of NOK 34m, compared to NOK 18m in the same period last year. The finished goods business delivered record fourth quarter and Full Year revenue and cash margin, with revenue at +68 %, NOK 31.7m, compared to 18.8m in the same period in 2021, and the fourth quarter alone delivering NOK 10.7m, compared to 3.7m last year. HBC h
